Session Details

Session Details

01:30 PM - 01:45 PM - Ballroom 3

Ayal Hendel - PhD - The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University

254: Precise Measurement of CRISPR Genome-Editing Outcomes through Single-Cell DNA Sequencing

01:30 PM - 03:15 PM - Ballroom 3

Douglas Smith - SeQure DX

Co-Chair

01:30 PM - 03:15 PM - Ballroom 3

Stephen Hart - PhD, MSc, BSc - UCL Great Ormond Street Institute of Child Health

Co-Chair

01:45 PM - 02:00 PM - Ballroom 3

Daniele Canarutto - MD PhD - SR-TIGET Telethon Institute for Gene Therapy

255: Heterogeneous On-Target Genomic Rearrangements Occur upon Long Range Gene Editing in T-Cells

02:00 PM - 02:15 PM - Ballroom 3

Meltem Isik - PhD - Excision BioTherapeutics

256: Selecting Highly Conserved and Specific Guide RNAs for CRISPR/CasX-Mediated Gene Editing of the HSV-1 Genome

02:15 PM - 02:30 PM - Ballroom 3

Zhe Zhang - University of Pennsylvania

257: In Silico Prediction Tool for Meganuclease Off-Target Sites

02:30 PM - 02:45 PM - Ballroom 3

Linsin Smith - Ph.D. - Epic Bio

258: Validating EPI-321 Safety for FSHD: A Comprehensive Off Target Characterization Platform for Epigenetic Gene Therapies

02:45 PM - 03:00 PM - Ballroom 3

Maria Collier - Prime Medicine, Inc.

259: Off-Target Analysis Shows Favorable Safety Profile of Prime Editing

03:00 PM - 03:15 PM - Ballroom 3

Robin Yeo - PhD - EPIC BIO

260: Casmini-Tool: A Comprehensive Database for Efficient and Specific Guide RNA Design Using dCasMINI